Background: Addiction is associated with disruptions in circadian rhythms. The circadian transcription factor neuronal PAS domain protein 2 (NPAS2) is highly enriched in reward-related brain regions, but its role in addiction is largely unknown.
Introduction
Circadian disruptions are a common symptom of many psychiatric disorders (1) (2) (3) and are thought to contribute to their etiology, including addiction (4) (5) (6) (7) . Diurnal rhythms in the behavioral responses to drugs of abuse are common, including drug sensitivity and motivation to seek and take drugs, which are typically more pronounced during active (dark) phase compared to the inactive (light) phase in nocturnal rodents (8, 9) . Chronic exposure to drugs of abuse alters circadian rhythms and these alterations may contribute to subsequent substance use and abuse (4, 5) . Emerging evidence from rodents and humans links disrupted circadian genes to substance abuse vulnerability (10) (11) (12) (13) (14) (15) (16) (17) , suggesting drug-induced alterations to these genes may augment drug-seeking.
Almost every cell in the brain and body expresses a molecular clock, comprised of several interlocking transcriptional-translational feedback loops (18) (19) (20) . The molecular clock is regulated by Circadian Locomotor Output Cycles Kaput (CLOCK) or its homologue, neuronal PAS domain protein 2 (NPAS2), which dimerize with Brain and Muscle ARNT-like 1 (BMAL1) to control transcription of many genes, including Period and Cryptochrome. After translation, these proteins enter the nucleus and inhibit the transcriptional activity of CLOCK/BMAL1, closing the negative feedback loop (20) . NPAS2 is similar to CLOCK in structure and function, yet these proteins are differentially enriched across reward-related brain regions. Relative to CLOCK, NPAS2 is highly expressed in the striatum (21) , including the nucleus accumbens (NAc), a major neural substrate of reward (reviewed in 22), suggesting NPAS2 may play an integral role in drug reward. Our laboratory has previously demonstrated that mutations in Clock lead to increased cocaine and alcohol intake in mice (15, 16, 23) and a loss of diurnal rhythmicity in cocaine self-administration (9) . We have also previously shown NPAS2 modulates cocaine conditioned reward. Interestingly, Clock mutation increases cocaine preference, while Npas2 mutation attenuates preference (24) . These results suggest that, despite their homology, CLOCK and NPAS2 might play unique roles in the regulation of reward.
This study aimed to determine whether NPAS2 regulates intravenous cocaine self-administration, a more translational model of drug taking, reinforcement, motivation, and relapse-like behavior. To investigate this, we used mice with a mutation in Npas2 which renders the protein non-functional (25) . We aimed to determine whether Npas2 mutation modulates the diurnal rhythm in drug taking by measuring cocaine self-administration during both the light and dark phase. Furthermore, evidence suggests both circadian rhythms (26) and addiction (27) are differentially regulated by sex, therefore we investigated whether Npas2 mutation will differentially impact male and female mice. Here, we found that NPAS2 regulates cocaine self-administration differentially across sex and time of day (TOD). Furthermore, ovarian hormones and cocaine-induced expression of striatal DFosB were associated with increased self-administration in Npas2 mutant females during the dark phase.
Methods and Materials
Subjects. Male and female Npas2 mutant mice or wild-type (WT) littermates, maintained on the C57BL/6J background, were used. These mice were originally described by . This mutation results in a form of NPAS2 lacking the bHLH domain, leaving NPAS2 intact, but incapable of binding to its partner BMAL1 (25) . Adult mice were maintained on a 12:12 light-dark cycle with lights on (Zeitgeber Time (ZT0)) at 0700 and 1900. Behavioral testing occurred from approximately ZT2-7 or ZT14-19 respectively for light and dark phase experiments. All mice were provided ad libitum food and water unless otherwise indicated. Procedures were approved by the University of Pittsburgh IACUC. Throughout, additional methodological details can be found in the supplement.
Drug.
Cocaine hydrochloride was generously provided by the National Institute on Drug Abuse. Animals were injected with 2.5, 5 or 15 mg/kg (intraperitoneal, i.p.; volume 10 ml/kg) in conditioned place preference and locomotor sensitization studies and 0-1 mg/kg/infusion for cocaine self-administrations studies. (15, 28) and ovariectomy (29) procedures were performed similarly to those previously described.
Surgery. Jugular catheterization

Behavioral testing.
Conditioned place preference (CPP). A biased conditioning protocol, adapted from published methods (30) , was used.
Locomotor sensitization. Locomotor activity was measured on day 1 for habituation, days 2-3 for saline treatment and days 4-8 and 16-17 for cocaine treatment.
Food and intravenous cocaine self-administration. Mice were trained to self-administer food (15) and then cocaine (adapted from 19) based on published methods.
Dual RNAscope and immunohistochemistry.
In order to measure the percent of D1+ and D1-neurons expressing DFosB, RNAscope in situ hybridization (ISH) for Drd1 was performed followed by immunohistochemistry (IHC) for DFosB. Mice were trained to self-administer cocaine and brains were extracted and flash frozen 24 hr after the last selfadministration session (timeline Fig.6a ). Frozen coronal sections were processed using an RNAscope fluorescent multiplex kit. Briefly, tissue sections were fixed, permeabilized to unmask target RNA, and hybridized with Drd1 probe. The signal was amplified and mounted sections were then blocked, incubated in rabbit anti-FosB primary antibody, rinsed and incubated in donkey anti-rabbit Alexa Fluor 555 secondary antibody. Sections were counterstained with DAPI and cover-slipped with prolong gold. Although a pan-FosB antibody was used, full-length FosB should degrade by the time of tissue harvesting (31), 24 hr after the last rewarding stimuli.
Therefore, all immunoreactivity reflects DFosB.
Imaging and cell counting.
Immunofluorescence images were captured on an Olympus IX83 confocal microscope using a 20x objective at x2 magnification (DAPI, Drd1 and DFosB). Approximately 300 x 300 µm images were taken from sections along the anterior-posterior extent of the NAc core and shell, and dorsomedial (DMS) and dorsolateral (DLS) striatum.
The total number of D1+ and D1-cells as well as the D1+ and D1-DFosB expressing cells (see Fig.6c ) were counted using ImageJ. The percentage of D1+ and D1-DFosB expressing cells was calculated for all conditions and brain regions.
Statistical Analyses.
GraphPad Prism 7 and IBM SPSS statistics (version 24) were used. Throughout, two-way ANOVAs were performed with significant interactions followed by Bonferroni post-hoc tests corrected for multiple comparisons.
Data are expressed as means+SEM with α=0.05 considered statistically significant and 0.05<α<0.1 considered a statistical trend.
Results
Sex differences in cocaine sensitization and place preference in Npas2 mutant mice
We first aimed to expand upon earlier evidence that NPAS2 regulates the behavioral effects of cocaine.
Prior work showed that male Npas2 mutant mice have reduced CPP for cocaine (30) , but female mice were not tested. Here, we conditioned mice to 2.5 or 5 mg/kg cocaine and found that sex plays a pivotal role in cocaine reward [sex x genotype interaction: 2.5 mg/kg (F(1,58)=4.4,p=0.04) and 5 mg/kg (F(1,57)=7.01,p=0.01)]. Male Npas2 mutant mice showed reduced CPP, replicating our prior findings, while female mutant mice showed no change ( Fig.1a ).
We next investigated whether another cocaine-related behavior, locomotor sensitization, is altered in a sex-dependent manner. Again, we found a significant effect of sex (sex x genotype interaction: Npas2 mutant mice self-administer more cocaine, particularly females in the dark phase We next examined the role of NPAS2 in a more translational model, intravenous cocaine selfadministration. In addition to sex and genotype, we also measured behavior at 2 times of day since Npas2 can influence circadian rhythms. Animals were first trained to respond for food during the light or dark phase; all mice acquired this response (session main effect: F(4,92)=524.72,p<0.0001) and discriminated between the levers (lever main effect: F(1,173)=212.83,p<0.0001). Response rates varied based on genotype and TOD (session x genotype x TOD interaction: F(4,173)=4.19,p=0.002), but not sex. Since prior behaviors showed explicit sex differences, the sexes were analyzed individually, but in this case only trending effects were found ( Fig.S1 ). Male
Npas2 mutant mice responded less on the last day of light phase food training (genotype x session interaction: F(4,204)=2.30,p=0.06), while female Npas2 mutant mice responded moderately more on session 4 of dark phase training (genotype x session interaction: F(4,128)=2.21,p=0.071).
After recovery from jugular catheterization, mice were trained to self-administer cocaine. Regardless of TOD, the Npas2 mutation differentially affected males and females (sex x genotype interaction: F(1,95)=4.18,p=0.044). When pooled across TOD, female Npas2 mutants self-administer significantly more cocaine than male mutants (F(1,49)=5.89,p=0.019) and female WT mice (F(1,41)=18.1,p=0.0001)( Fig.2a ). We also confirmed that all mice self-administer more cocaine during the dark (active) phase (session x TOD interaction: F(13,1300)=2.11,p=0.012), which is expected since mice are nocturnal ( Fig.2b) . In order to further parse the effects of mutating Npas2 on cocaine self-administration, female and male data will be shown separately for the light and dark phases throughout. During the light phase, males (genotype main effect: F(1,29)=7.27,p=0.012), but more so females (session x genotype interaction: F(13,351)=1.82,p=0.039), take more infusions of cocaine relative to WT mice ( Fig.2cd ). During the dark phase, this sex difference was exacerbated with mutant females continuing to self-administer more cocaine (session x genotype interaction: F(13,247)=6.43,p=0.05), while mutant males showed no differences (Fig2.ef).
To further illustrate the effects of loss of NPAS2 function on cocaine self-administration, we analyzed sessions required to reach criteria and total drug intake (infusions). We again found the Npas2 mutation differentially affected males and females (sex x genotype interaction: infusions F(1,95)=3.76,p=0.055). TOD was also critically important (sex x genotype x TOD interaction: criteria F(1,95)=3.08,p=0.08), with sex differences emerging during dark phase self-administration. All Npas2 mutant mice acquired self-administration faster and took more infusions than WT mice in the light phase [genotype main effects: criteria (F(1,52)=4.32,p=0.043), infusion (F(1,57)=16.41,p=0.0002)]( Fig.S2ab ), but in the dark phase these effects were only found in females [sex x genotype interaction: criteria (F(1,39)=3.92,p=0.055), infusion (F(1,39)=3.12,p=0.085)]( Fig.S2cd ).
Increased reinforcing properties of cocaine in Npas2 mutant mice
Following acquisition, we investigated the reinforcing properties of cocaine using a dose-response analysis. No sex or TOD differences were found ( Fig.3ab ). Throughout, Npas2 mutant mice earned more female Npas2 mutants took more infusions across dose (genotype main effect: F(1,17)=5.05,p=0.038), while male mutants took more infusions at lower doses (dose x genotype interaction: F(5,95)=3.55,p=0.006)( Fig.3ef ). During the dark phase, male mutants took more infusions at the lowest dose (dose x genotype interaction: F(5,90)=2.84,p=0.0198), while females took more at the three lowest doses (dose x genotype interaction: F(5,90)=8.55,p<0.0001)( Fig.3ij ). Saline infusions were also increased in all female mutant mice, which is likely due to the descending unit dose procedure used or greater responding under extinction conditions in these mice.
Increased motivation, extinction responding, and cue-induced reinstatement in female Npas2 mutant mice in the dark phase Next, a progressive ratio schedule was used to measure motivation for cocaine as shown by increases in a breakpoint ratio. Similar to the reinforcing properties of cocaine, we found no TOD or sex differences associated with motivation ( Fig.3cd ). However, when males and females were analyzed separately, genotype only affected motivation in females (Fig.3gk ). This was particularly true in the dark phase (genotype main effect: F(1,13)=4.50,p=0.05)( Fig.3k ), compared to the light phase (main effect: F(1,12)=3.52,p=0.085)( Fig.3g ).
Mice then underwent extinction and cue-induced reinstatement to model relapse-like drug seeking in the absence of cocaine. We confirmed that all mice extinguished responding (session main effect: F(9,432)=28.68,p<0.0001) and found a trending 4-factor interaction (session x sex x genotype x TOD interaction: F(9,432)=1.85,p=0.058) indicating divergent effects of genotype on males and females in the light and dark phase.
Female Npas2 mutants respond significantly more during extinction compared to male mutants (F(1,31)=5.3,p=0.028) and female WT mice (F(1,26)=6.86,p=0.015) when pooled across TOD (Fig.4a ). When male and female mice were pooled, Npas2 mutants responded more during extinction compared to WT mice, but only during the dark phase (F(1,27)=4.27,p=0.049) ( Fig.4b ). When analyzed separately by sex and TOD, only female Npas2 mutant mice in the dark phase were affected ( Fig.4i ), as shown by increased responding during early extinction (session x genotype interaction: F(9,108)=2.71,p=0.007). This indicates that in the absence of cocaine, female Npas2 mutants will escalate their drug seeking, but only in the dark phase.
After extinction, mice were presented with a previously cocaine associated audio-visual cue, followed by contingent cues for each subsequent lever press. In the absence of cocaine, these cues invigorated or reinstated responding in all mice (lever main effect: F(1,48)=53.38,p<0.0001). Although no TOD differences were found, a sex x genotype interaction was detected (F(1,48)=4.49,p=0.039) again indicating that mutating Npas2 differentially affects males and females (Fig.4cd) . Female Npas2 mutants self-administer significantly more cocaine than male mutants (F(1,31)=9.26,p=0.005) and female WT mice (F(1,26)=5.11,p=0.033) (Fig.4a ). Similar to extinction, in subsequent analysis we only detected an increase in active lever pressing in female Npas2 mutants in the dark phase (lever x genotype interaction: F(1,12)=4.58,p=0.054)( Fig.4k ), further indicating an increase in drug seeking in the absence of cocaine.
Circulating sex hormones contribute to increased cocaine self-administration in female Npas2 mutant mice In order to determine whether ovarian hormones are contributing to sex differences in cocaine selfadministration in Npas2 mutant mice, a separate cohort of female mice underwent a sham surgery or ovariectomy (OVX). Mice were then trained to self-administer food and later drug following recovery from jugular catheterization. This experiment was conducted during the dark phase where we observed the largest behavioral effect. While sham surgery mice recapitulated our original finding, increased self-administration of cocaine in dark phase mutant females (genotype main effect: F(1,18)=4.09,p=0.058)( Fig.5a ), no genotype effect was found in OVX mice (Fs<1) (Fig.5b ). Furthermore, daily infusions self-administered during maintenance (days 7-14 based on stable responding onset in Fig.2e and Fig.5ab ) were increased in sham mutant females (t(18)=1.83,p=0.042)( Fig.5c ), but not OVX mutant females compared to WT controls (t(15)=1.06,p=0.153) (Fig.5d ).
These findings suggest that circulating sex hormones could be contributing to the greater effects of Npas2 mutation seen in female mice.
Increased DFosB expression in D1+ neurons in Npas2 mutant females following dark phase cocaine selfadministration In order to determine which striatal regions might be mediating increased self-administration in Npas2 mutant females, we measured cocaine-induced expression of DFosB, a stable, long-lasting variant of FosB, in the dorsal and ventral striatum. Female mice were trained to self-administer cocaine during either the light or dark phase. In order to control for total cocaine intake, infusions were limited to 25; cocaine self-administration was normalized between WT and Npas2 mutant mice [no genotype main effect: light (F(1,9)=2.73,p=0.133), dark (F<1); genotype x session interaction: light (F<1), dark (F(13,117)=2.23,p=0.012, no significant post-hoc tests)], as was total drug intake [light (t(9)=1.91,p=0.089), dark (t<1)] (Fig.S3 ). Tissue was harvested 24 hr after the last selfadministration session (Fig.6a ).
The percentage of D1+ and D1-cells expressing DFosB in the NAc core, NAc shell, DLS and DMS were quantified (Fig.6c ). No genotype differences were found in DFosB expression after light phase self-administration, but dark phase Npas2 mutant females had increased DFosB expression in the NAc shell 
Discussion
Overall, loss of NPAS2 function increases vulnerability to substance use, particularly in females during the active phase. Specifically, a non-functional variant of NPAS2 increases cocaine intake and the propensity to self-administer cocaine, as well as the reinforcing and motivational properties of cocaine. Interestingly, NPAS2 seems to affect reward in a circadian-dependent manner, where effects are not only greater and more frequent in females during the dark phase, but sex differences are exacerbated (Table1).
Interestingly, these changes occur without a baseline increase in cocaine reward in female Npas2 mutants as measured by CPP. While males show contradicting effects of Npas2 mutation on cocaine reward and self-administration during the light phase, females show a more synergistic phenotype with no change in cocaine reward, but an increase in self-administration. Although it isn't uncommon to find opposing results for these disparate drug-related behaviors (32, 33) , it is more common to only detect a change in self-administration where active, volitional, chronic drug intake is being measured, as with females here.
Here we found a collective phenotype across behaviors where females are affected by Npas2 mutation differently than males: females show no change in CPP, but an increase in the locomotor-activating effects of cocaine and self-administration, whereas males show a decrease, no change, and a slight increase respectively.
The only behavior tested that is consistently increased across groups is drug intake during a dose-response analysis. Since cocaine reinforcement is similarly affected, while other addiction-related behaviors are only affected in females, it is possible that estradiol is interacting with increased reinforcement to drive drug taking and seeking in females.
Despite these and previous findings suggesting circadian genes regulate drug taking and reward, little is known about how alterations in circadian genes contribute to problematic drug use. In order to examine possible mechanisms, we first ovariectomized female mice before dark phase cocaine self-administration to determine whether circulating ovarian hormones contribute to the effects of Npas2 mutation. We confirmed that increased self-administration in female mice with non-functional NPAS2 is absent in ovariectomized mice. This suggests that ovarian hormones contribute to the role of Npas2 in drug taking and could be driving the enhanced effects seen in mutant females compared to males.
It is well known that sex differences exist in circadian rhythms and that circulating estradiol contributes to these differences in rodents. Locomotor activity rhythms vary by sex (reviewed in 35) where wheel-running in constant darkness shows increased daily activity in females, but longer activity duration in males (35) . It is also typical to observe sex differences in the rhythmicity of peripheral circadian genes (Rev-erba, Cry1 and Bmal1) (36) . While few studies have been done in brain tissue, recent findings demonstrate that human females show earlier peaks in several circadian genes (Per2, Per3, and Bmal1) in the prefrontal cortex (37) . In rodents, the robustness of diurnal variations in clock genes can vary by sex and brain region (38) . Sex differences are also extremely robust in the master pacemaker, the suprachiasmatic nucleus (SCN) (39) . In rodents, SCN volume is increased in males (40) , as are firing rates in the SCN shell during the light phase (41) . This parallels our current work and supports the idea that sex differences can be varied across the 24-hr period.
Despite the abundance of evidence indicating an intersection between rhythms and hormones, neuroscience and behavioral research investigating the link between molecular rhythms and sex is limited.
Whereas estrogens affecting the output of behavioral rhythms is likely due to sexual dimorphisms in the SCN, evidence that estrogens regulate the expression of circadian clock genes in the extra-SCN brain indicates SCNindependent behaviors could also be affected (37, 38) . These findings are relatively recent, therefore very few papers have examined sex differences in how altered circadian rhythms, for example from mutating circadian genes, affect behavior. As with our results, studies that have utilized both sexes found significant differences.
For example, female Clock mutant mice show more robust increases in exploratory and escape-seeking behavior (42) and Npas2 mutation affects sleep homeostasis differentially in male and female mice (43) .
Given the critical role sex plays in circadian rhythms and the behaviors they regulate, future studies examining the role circadian genes play in behavior across sex are imperative. This is particularly true in neuroscience, since there are strong sex differences in the occurrence and features of many psychiatric disorders, including addiction. In humans, women tend to escalate drug use more quickly, have more severe cocaine use disorder when seeking treatment and report more cue-related craving (27, (44) (45) (46) . It is also important to study extra-hormonal factors, such as chromosomal sex. For example, chromosomal female mice (XX) have a longer activity duration regardless of gonadal state (41) . Future studies could take advantage of the available four core genotype mice (47) in order to dissect the organizational, activational and chromosomal effects of sex on circadian rhythms and the behaviors regulated by these rhythms.
We also sought to determine which brain regions might be involved in the increased self-administration in Npas2 mutant females using DFosB expression as a marker of activation. While other Fos family proteins are transiently induced by drug exposure, DFosB is a stable, long-lasting variant induced by chronic administration of drugs of abuse, including cocaine, in the NAc of mice and humans (48) . This allows activation due to chronic drug exposure to be measured, in lieu of acute cocaine-induced activation. Here, female WT and Npas2 mutant mice self-administered cocaine, but drug intake was limited in order to avoid greater cocaine intake, and therefore greater DFosB induction, in mutant mice.
We measured DFosB expression in D1+ and D1-cells in various subregions of the striatum. The striatum is primarily comprised of medium spiny neurons, subdivided into populations expressing D1 or D2 dopamine receptors (49) , which contribute differentially to reward-related behaviors (50) (51) (52) . For example, activation of D1expressing neurons in the NAc promotes cocaine preference (52) . In addition, cocaine activates D1 and D2 receptors differently (53) and induces DFosB specifically in D1 medium spiny neurons (54) . NPAS2 is also enriched in D1-expressing neurons (30) and recent work from our lab has shown that Npas2 knockdown in the NAc increases glutamatergic excitability (AMPA/NMDAR ratio) specifically in D1 cells (55) . Therefore, we expected Npas2 mutation to affect DFosB expression in D1+ cells. Indeed, we found that DFosB expression was increased in D1+ neurons in the NAc core and DLS of Npas2 mutant females.
Although DFosB expression was increased in mutant mice in both the NAc core and shell (across celltype), it was confined to the DLS. Interestingly, the DLS is thought to mediate habitual drug seeking, whereas the DMS mediates goal-directed decision making (56) . This finding suggests the DLS is more highly recruited, and therefore, habitual decision-making strategies are more heavily relied upon during cocaine selfadministration in Npas2 mutant females than in WT controls. Since a bias towards habitual decision-making strategies is considered an etiological factor in addiction (57) , future studies could utilize other behavioral paradigms, such as action-outcome contingency degradation or outcome devaluation, to measure the biases of Npas2 mutant females towards habitual response strategies.
Increased induction of DFosB in Npas2 mutants was also only found during the dark phase when the behavioral effects of Npas2 mutation were greatest. Npas2 expression is normally highest in the NAc during the dark phase around ZT16 (58) when behavior was occurring during these experiments. It stands to reason that mutating Npas2 would have a greater impact on behavior when mRNA expression is normally elevated. Higher expression suggests a functional necessity for NPAS2, however, a parallel rhythm in protein expression has not yet been confirmed. Furthermore, drug intake is typically higher during the dark phase, therefore, mice could be more vulnerable to other insults during this time of predisposed drug seeking.
Cocaine-induced expression of the transcription factor DFosB is also a hypothesized mechanism underlying the long-term effects of cocaine. Similar to the effects of Npas2 mutation, overexpression of DFosB in D1 neurons in the NAc increases self-administration of cocaine (59, 60) , indicating DFosB accumulation after drug administration is functionally relevant. Overexpression of DFosB also impacts neuronal physiology and morphology, increasing dendritic spine density (61) and decreasing excitatory synaptic strength onto D1expressing neurons (62) . DFosB-induced changes in cellular morphology and physiology could underlie increases in addiction-related behaviors in Npas2 mutant mice, particularly long-term changes which would allow for greater accumulation, such as maintenance levels of self-administration and cue-induced reinstatement.
Future studies could examine whether augmented DFosB expression in Npas2 mutant females contributes to increased cocaine self-administration, as well as how Npas2 mutation affects physiology and dendritic spine morphology in the NAc and DLS, specifically in the dark phase.
Ultimately, these results demonstrate that decreased function in NPAS2 drives vulnerability for substance use through increased cocaine intake, increased locomotor-activating, reinforcing and motivational effects of cocaine, impaired extinction, and enhanced drug seeking during cue-induced reinstatement. NPAS2 appears to affect reward in a circadian-dependent manner and is associated with cocaine-induced DFosB expression in the NAc and DLS. These effects could be augmented by circulating sex hormones, leading to an increased effect of Npas2 mutation in females. Npas2 mutant mice showed a decrease in conditioned place preference to cocaine (2.5 and 5 mg/kg), whereas females showed no change. (B) One cohort of mice were then tested for locomotor sensitization. All mice showed sensitization to cocaine, but female Npas2 mutant mice also showed elevated locomotor-activating Npas2 mutant mice self-administered significantly more infusions of cocaine during a dose-response analysis (0-1 mg/kg/infusion). Neither (A) sex, nor (B) time of day affected how Npas2 mutant mice self-administered cocaine. Both (E) female (F) and male mutant mice similarly took more infusions during the light phase. During the dark phase, (I) female Npas2 mutant mice had a slightly greater increase in intake compared to (J) male mutants. During progressive ratio testing, again no (C) sex or (D) time of day differences were found. However, when data were separated by sex and phase similarly to prior experiments, we found that (G) female Npas2 mutant mice tended to work harder for each infusion of cocaine, as shown by a higher breakpoint ratio, (K) particularly in the dark phase. (H,L) On the other hand, male Npas2 mutant mice during the light and dark phase did not show changes in the motivational properties of cocaine. Means+SEMs, # p<0.1; *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001, n=4-11 E-L. that Npas2 mutant females take more cocaine than their WT counterparts during acquisition. (B) On the other hand, OVX seemed to reverse this effect with no differences seen between mutant and WT mice. These results were confirmed by average infusions during maintenance responding, which are (C) increased in sham treated Npas2 mutant mice, but not (D) OVX mice. Means+SEMs, # p<0.1; *p<0.05, n=7-12. experimental design, wherein a separate cohort of female mice were trained to self-administer cocaine during either the light phase or dark phase. Infusions were limited to 25 in order to normalize cocaine intake between groups. (B) No differences were found between genotypes in FosB expression following light phase cocaine self-administration. However, following dark phase self-administration FosB expression was increased in
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